Talking about "imminent realities", one should look at the current state of the whole sector:
https://www.cnbc.com/2026/02/13/pharma-earnin...aways.html
with patents about to expire and companies holding cash, ready to pull the trigger.
Also "historical norms and market research" won't mean a thing IF !! our results are good aka triggering a bidding war.
https://www.cnbc.com/2026/01/07/big-pharma-ra...looms.html
Merck's Keytruda is about to lose its yearly $30B revenue, on top of that much higher numbers were in talks for far less profitable drugs:
https://www.reuters.com/business/healthcare-p...026-01-08/
$5 B valuation?? That would be a joke no matter what, especially with additionally looming mtnbc results, hopefully until that time.